Your browser does not support JavaScript
 

RSV VACCINE

An adolescent receiving a vaccine

Sterling Research Group is seeking healthy participants age 60-65 for a Respiratory Syncytial Virus (RSV) vaccine study. This study will help determine the safety and efficacy of an investigational vaccine intended to protect against RSV, a common respiratory virus that can be serious in infants and immunocompromised individuals. Eligible participants will receive compensation for participation and do not need health insurance to join.

Call (513) 621-5112 for more information or CLICK HERE to have someone contact you. 
 
 
 
Call for Participation
  Cincinnati / Mt. Auburn 
  Springdale 
Our Services
Patient Recruitment Specialist
Cincinnati, OH 

 (513) 621-5112
 (513) 621-5101
  2230 Auburn Avenue Level B 
Cincinnati, OH 45219 


 (513) 381-4100
 (513) 381-4120
  375 Glensprings Drive 2nd Flr
Cincinnati, OH 45246
 

 (513) 671-8080
 (513) 671-8090
About Us
Active Studies
Study Participants
About Clinical Trials
Sponsors/CROS
Blog
Careers

2021. STERLING RESEARCH. ALL RIGHTS RESERVED